Serial rises in pro-GRP and NSE levels have been noted to mirror SCLC transformation in numerous case reports and deserve further studies to determine their clinical utility in patients EGFR TKI-treated NSCLCs [55,56,57]. This evidence concerns the gene ENO2 and small cell lung carcinoma.